Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine

Keyphrases

• SCN2A mutation 100%
• Infantile Epileptic Encephalopathy 100%
• Mexiletine 100%
• Early Onset 66%
• Seizure Frequency 66%
• SCN2A 66%
• Genetic Modification 33%
• Epileptic 33%
• Voltage Gating 33%
• Epilepsy Syndrome 33%
• Lidocaine 33%
• Medically Refractory 33%
• First child 33%
• Antiarrhythmic Agents 33%
• Intravenous Lidocaine 33%
• Generalized Epilepsy 33%
• Medically Refractory Seizures 33%
• Voltage-gated Sodium Channel 33%
• Causes of Epilepsy 33%
• Sodium Channelopathy 33%
• Benign Familial Infantile Epilepsy 33%
• Febrile Seizures Plus 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Disease 100%
• Mexiletine 100%
• Lidocaine 66%
• Syndrome 33%
• Voltage Gated Sodium Channel 33%
• Febrile Convulsion 33%
• Sodium Channelopathy 33%
• Epilepsy 33%
• Antiarrhythmic Agent 33%
• Generalised Epilepsy 33%